Skip to main content
Fig. 1 | Hereditary Cancer in Clinical Practice

Fig. 1

From: Mainstream genetic testing for women with ovarian cancer provides a solid basis for patients to make a well-informed decision about genetic testing

Fig. 1

Study design and participation in questionnaire study. aTwo questionnaires were returned without being completed and with a comment that the patient had died. bPatients in the control group received pre-test genetic counseling both before and during our study period (from January 2017 until April 2020). Patients who received genetic counseling during our study period received the questionnaire approximately four weeks after the test result was made available. Patients who received genetic counseling before our study period received the questionnaire between four weeks and one year after receiving the test result. cTwo patients were excluded after receiving the questionnaire, one because of a language barrier and one because the patient received counseling for breast cancer and the EOC was diagnosed after preventive surgery

Back to article page